A first in-human, phase I trial examined feasibility as well as safety ...

Teeth, placentas and surgical remains are being saved and even consumed. Here is what medicine says about safety.

A Phase I clinical trial published in The Lancet has shown that combining stem cell therapy with standard fetal surgery ...

A phase 1 clinical trial published in The Lancet has shown that combining stem cell therapy with standard fetal surgery before birth is a safe and promising approach to treat myelomeningocele, a ...

The congenital condition spina bifida is often treated surgically in the womb, but many children still go on to have mobility issues. The addition of a patch made up of stem cells from donated placent ...

Six pregnant women participated in a small trial in which placenta-derived stem cells were applied to fetal spinal cords and the treatment was found to be safe.

Repair of open neural tube defects, including myelomeningocele, in the fetus has been shown to improve postnatal outcomes by decreasing the severity of hydrocephalus and, consequentially, reducing the ...